Skip to main content

Medication & Treatment

People with diabetes use many medications to both manage blood sugar levels and also to prevent or treat health complications.

For people with type 1 diabetes, the most important drug is insulin; some people with type 2 diabetes also take insulin. For people with type 2 diabetes, glucose-lowering medications include metformin, sulfonylureas, TZDs, SGLT-2 inhibitors, GLP-1 agonists, DPP-4 inhibitors, and more.

Some of these drugs are injected, others are taken in pill form, and some are even inhaled. Learn about the different treatment options available and which might be best for your lifestyle.

Metformin
Insulin
SGLT-2 inhibitors
GLP-1 agonists
DPP-4 inhibitors
Combination drugs
Sulfonylureas (SFUs)
TZDs

What's new

SGLT-2 inhibitor Farxiga shows impressive results from its latest clinical trial: it slows the loss of kidney function and reduces the risk of death in people with chronic kidney disease, with or without type 2 diabetes Continue Reading »

We interviewed Dr. Partha Kar to learn about how people are using time in range in his clinic and what obstacles our society will need to overcome to promote wider use of time in range  Continue Reading »

Michael Hattori – a nurse, diabetes educator, and person with diabetes – explains the health complications associated with type 2 diabetes, how to prevent them, and what to ask your healthcare team Continue Reading »

The FDA has announced that 14 companies have voluntarily recalled their extended release metformin due to the possibility that it includes unsafe levels of NDMA, a toxic substance Continue Reading »

InPen – a reusable, Bluetooth-enabled, smart insulin dosing and tracking pen – is now available for people of all ages in the United States Continue Reading »

Lyumjev reduces blood glucose spikes and can be taken at the beginning of a meal, or even 20 minutes into the meal; available through Lilly’s insulin affordability program Continue Reading »

The ready-to-use autoinjector emergency glucagon pen is now available for people over the age of two in the US Continue Reading »

Results from the VERTIS-CV trial show that SGLT-2 inhibitor Steglatro benefits heart and kidney health; hear expert opinions on SGLT-2 and GLP-1 medications Continue Reading »

Pages